1. Home
  2. ASMB vs LFVN Comparison

ASMB vs LFVN Comparison

Compare ASMB & LFVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASMB
  • LFVN
  • Stock Information
  • Founded
  • ASMB 2005
  • LFVN N/A
  • Country
  • ASMB United States
  • LFVN United States
  • Employees
  • ASMB 73
  • LFVN N/A
  • Industry
  • ASMB Biotechnology: Pharmaceutical Preparations
  • LFVN Biotechnology: Pharmaceutical Preparations
  • Sector
  • ASMB Health Care
  • LFVN Health Care
  • Exchange
  • ASMB Nasdaq
  • LFVN Nasdaq
  • Market Cap
  • ASMB 198.6M
  • LFVN 162.8M
  • IPO Year
  • ASMB 2010
  • LFVN N/A
  • Fundamental
  • Price
  • ASMB $25.50
  • LFVN $13.10
  • Analyst Decision
  • ASMB Strong Buy
  • LFVN Strong Buy
  • Analyst Count
  • ASMB 4
  • LFVN 2
  • Target Price
  • ASMB $38.67
  • LFVN $30.50
  • AVG Volume (30 Days)
  • ASMB 147.2K
  • LFVN 84.7K
  • Earning Date
  • ASMB 08-06-2025
  • LFVN 10-28-2025
  • Dividend Yield
  • ASMB N/A
  • LFVN 1.37%
  • EPS Growth
  • ASMB N/A
  • LFVN 152.87
  • EPS
  • ASMB N/A
  • LFVN 0.70
  • Revenue
  • ASMB $33,247,000.00
  • LFVN $222,347,000.00
  • Revenue This Year
  • ASMB $12.44
  • LFVN $17.36
  • Revenue Next Year
  • ASMB N/A
  • LFVN $9.60
  • P/E Ratio
  • ASMB N/A
  • LFVN $18.70
  • Revenue Growth
  • ASMB 54.77
  • LFVN 8.22
  • 52 Week Low
  • ASMB $7.75
  • LFVN $7.09
  • 52 Week High
  • ASMB $27.17
  • LFVN $27.38
  • Technical
  • Relative Strength Index (RSI)
  • ASMB 65.04
  • LFVN 49.27
  • Support Level
  • ASMB $24.98
  • LFVN $12.53
  • Resistance Level
  • ASMB $27.17
  • LFVN $14.08
  • Average True Range (ATR)
  • ASMB 1.13
  • LFVN 0.76
  • MACD
  • ASMB -0.06
  • LFVN -0.04
  • Stochastic Oscillator
  • ASMB 64.24
  • LFVN 35.15

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About LFVN Lifevantage Corporation (Delaware)

Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.

Share on Social Networks: